Scott McBride

928 total citations
18 papers, 579 citations indexed

About

Scott McBride is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Scott McBride has authored 18 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 4 papers in Cardiology and Cardiovascular Medicine and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Scott McBride's work include Lipoproteins and Cardiovascular Health (6 papers), Respiratory viral infections research (3 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Scott McBride is often cited by papers focused on Lipoproteins and Cardiovascular Health (6 papers), Respiratory viral infections research (3 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Scott McBride collaborates with scholars based in United States, United Kingdom and Sweden. Scott McBride's co-authors include Roger S. Newton, Janice R. Margulies, Diane MacDougall, Paul M. Thompson, John Rubino, Matthew Janik, Jeffrey C. Hanselman, María J. Gutiérrez, Mark A. Milad and Poul Strange and has published in prestigious journals such as Blood, Journal of the American College of Cardiology and Cancer.

In The Last Decade

Scott McBride

17 papers receiving 548 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Scott McBride United States	10	386	136	132	101	98	18	579
Janice R. Margulies United States	7	540 1.4×	224 1.6×	241 1.8×	103 1.0×	35 0.4×	12	840
Yuling Dai United States	12	266 0.7×	89 0.7×	78 0.6×	151 1.5×	95 1.0×	25	647
Haseeb Jafri United States	6	185 0.5×	38 0.3×	98 0.7×	55 0.5×	48 0.5×	11	409
Paul J. Dluzniewski United States	11	155 0.4×	35 0.3×	90 0.7×	64 0.6×	98 1.0×	22	478
Krista M. Dale United States	7	362 0.9×	69 0.5×	79 0.6×	46 0.5×	133 1.4×	10	646
Issa Alesh United States	9	519 1.3×	73 0.5×	233 1.8×	128 1.3×	41 0.4×	21	982
J.P. Empana France	9	206 0.5×	58 0.4×	107 0.8×	54 0.5×	59 0.6×	10	540
Barbara Iyen United Kingdom	11	147 0.4×	46 0.3×	52 0.4×	78 0.8×	192 2.0×	27	520
Hayley Bennett United Kingdom	16	52 0.1×	144 1.1×	152 1.2×	77 0.8×	152 1.6×	52	680
Pooja Ramakant India	12	223 0.6×	78 0.6×	248 1.9×	27 0.3×	49 0.5×	59	759

Countries citing papers authored by Scott McBride

Since Specialization

Citations

This map shows the geographic impact of Scott McBride's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott McBride with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott McBride more than expected).

Fields of papers citing papers by Scott McBride

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott McBride. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott McBride. The network helps show where Scott McBride may publish in the future.

Co-authorship network of co-authors of Scott McBride

This figure shows the co-authorship network connecting the top 25 collaborators of Scott McBride. A scholar is included among the top collaborators of Scott McBride based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott McBride. Scott McBride is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Anderson, Evan J., John P. DeVincenzo, Eric A. F. Simões, et al.. (2019). SENTINEL1: Two-Season Study of Respiratory Syncytial Virus Hospitalizations among U.S. Infants Born at 29 to 35 Weeks' Gestational Age Not Receiving Immunoprophylaxis. American Journal of Perinatology. 37(4). 421–429. 50 indexed citations

Anderson, Evan J., Leonard R. Krilov, John P. DeVincenzo, et al.. (2016). SENTINEL1: An Observational Study of Respiratory Syncytial Virus Hospitalizations among U.S. Infants Born at 29 to 35 Weeks' Gestational Age Not Receiving Immunoprophylaxis. American Journal of Perinatology. 34(1). 51–61. 46 indexed citations

Thompson, Paul M., John Rubino, Matthew Janik, et al.. (2015). Use of ETC-1002 to treat hypercholesterolemia in patients with statin intolerance. Journal of clinical lipidology. 9(3). 295–304. 121 indexed citations

Krilov, Leonard R., Natasha Halasa, Neal J. Thomas, et al.. (2015). SENTINEL 1: An Observational Study of Respiratory Syncytial Virus Hospitalizations Among United States Infants Born at 29–35 Weeks' Gestational Age Not Receiving Immunoprophylaxis. Open Forum Infectious Diseases. 2(suppl_1). 1 indexed citations

Xuan, Dawei, Scott McBride, Philip Wastall, et al.. (2015). Safety, pharmacokinetics, and pharmacodynamics of PD 0348292, an oral, direct factor Xa inhibitor, after single and multiple dosings in healthy subjects. Clinical Pharmacology in Drug Development. 5(1). 13–26. 2 indexed citations

Gutiérrez, María J., Diane MacDougall, Jeffrey C. Hanselman, et al.. (2014). Efficacy and Safety of ETC-1002, a Novel Investigational Low-Density Lipoprotein-Cholesterol–Lowering Therapy for the Treatment of Patients With Hypercholesterolemia and Type 2 Diabetes Mellitus. Arteriosclerosis Thrombosis and Vascular Biology. 34(3). 676–683. 135 indexed citations

Newton, Roger S., Paul D. Thompson, Diane MacDougall, et al.. (2014). ETC-1002 Lowers LDL-Cholesterol and is Well Tolerated in Hypercholesterolemic Patients with Statin Intolerance†. Journal of clinical lipidology. 8(3). 340–341. 3 indexed citations

Newton, Roger S., Christie M. Ballantyne, Paul D. Thompson, et al.. (2014). ETC-1002 Lowers LDL-Cholesterol and is Well Tolerated in Hypercholesterolemic Patients Across Four Phase 2a Studies. Journal of clinical lipidology. 8(3). 339–340. 3 indexed citations

MacDougall, Diane, Jeffrey C. Hanselman, Mark A. Milad, et al.. (2013). ETC-1002 Lowers LDL-Cholesterol and Beneficially Modulates Other Cardio-Metabolic Risk Factors in Hypercholesterolemic Subjects†. Journal of clinical lipidology. 7(3). 283–283.

10.

Cohen, Alexander T., Donald Armstrong, T Gaździk, et al.. (2008). An Adaptive-Design Dose-Ranging Study of PD 0348292, a New Oral Factor Xa Inhibitor, for Thromboprophylaxis after Total Knee Replacement Surgery.. Blood. 112(11). 980–980. 10 indexed citations

11.

Kirby, Simon, et al.. (2003). An Example of an Unblinded, Third-Party Interim Analysis for Sample Size Re-estimation. Drug Information Journal. 37(3). 317–320. 2 indexed citations

12.

Rajagopalan, Sanjay, Jeffrey Trachtenberg, Jeffrey W. Olin, et al.. (2002). Long-term safety and efficacy of intramuscular administration of Cl-1023 (AdGVVEGF121.10) in patients with intermittent claudication. Journal of the American College of Cardiology. 39. 205–205. 1 indexed citations

13.

Rajagopalan, Sanjay, Jeffrey Trachtenberg, Emile R. Mohler, et al.. (2002). Phase I study of direct administration of a replication deficient adenovirus vector containing the vascular endothelial growth factor cDNA (CI-1023) to patients with claudication. The American Journal of Cardiology. 90(5). 512–516. 40 indexed citations

14.

McBride, Scott, et al.. (2002). Randomized comparison of enoxaparin with unfractionated heparin following fibrinolytic therapy for acute myocardial infarction. ACC Current Journal Review. 11(5). 15–15. 2 indexed citations

15.

Szucs, Thomas D., et al.. (1999). Cost of Treating to a Modified European Atherosclerosis Society LDL-C Target. Clinical Drug Investigation. 17(3). 185–193. 19 indexed citations

16.

Gimotty, Phyllis A., Julie George, Scott McBride, et al.. (1998). How reminders given to patients and physicians affected pap smear use in a health maintenance organization. Cancer. 82(12). 2391–2400. 53 indexed citations

17.

Simon, Michael S., et al.. (1998). Factors Affecting Participation in a Mammography Screening Program among Members of an Urban Detroit Health Maintenance Organization. Cancer Detection and Prevention. 22(1). 30–38. 29 indexed citations

18.

Hunninghake, D B, et al.. (1998). Treating to meet NCEP-recommended LDL cholesterol concentrations with atorvastatin, fluvastatin, lovastatin, or simvastatin in patients with risk factors for coronary heart disease.. PubMed. 47(5). 349–56. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact